US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.

J Clin Oncol

Melanie Royce, MD, PhD, Flora Mulkey, MS, Christy Osgood, MD, Erik Bloomquist, PhD, and Laleh Amiri-Kordestani, MD, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.

Published: June 2023

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.23.00615DOI Listing

Publication Analysis

Top Keywords

food drug
4
drug administration
4
administration expanded
4
expanded adjuvant
4
adjuvant indication
4
indication abemaciclib
4
abemaciclib high-risk
4
high-risk early
4
early breast
4
breast cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!